Wound Care Biologics Market Size, Share & Growth Report 2031

Report Description

Wound Care Biologics Market Outlook 2031

The wound care biologics market size was valued at USD 1.78 Billion in 2022 and is projected to reach USD 2.76 Billion by 2031, expanding at a CAGR of around 5% during the forecast period, 2023 – 2031. The growth of the market is attributed to the rising cases of burn injuries.

Biologics for wound care products produce an environment that is conducive to active healing, allowing the body to heal wounds naturally. Biochemically active substances, such as active biomolecules produced from plants that have anti-inflammatory, antibacterial, or antioxidant properties, may be applied as part of biologic wound healing therapies, which aim to facilitate the restoration of the body's own repair mechanisms.

Get Free Sample Report

Biological dressings reduce contamination, protein and electrolyte loss, heat loss, evaporative water loss, and loss of heat. They also promote the development of a granular wound bed and autolytic debridement. Burn incidents are very common in places like Brazil and Africa. For instance, the WHO estimated that each year around 180,000 fatalities occur in low and middle-income countries.

Burns not only have a significant financial impact, but also have terrible consequences for the skin of the victim. There are various treatment methods for burns, which are categorized based on the severity of the injury. The availability of high-quality synthetic alternatives and the rising demand for them in the treatment of burns has benefited the market growth.

The advent of the COVID-19 pandemic has transformed how medical treatment is provided globally. Numerous hospitals and departments were re-profiled for treating patients with COVID-19 as a result of the increasing pressure brought on by the rising prevalence of COVID-19 diagnoses. In order to reserve or redistribute the limited resources and expertise toward COVID-19 patient care, numerous elective procedures were cancelled or delayed worldwide.

Wound Care Biologics Market Trends, Drivers, Restraints, and Opportunities

• Increasing cases of chronic wounds is projected to drive the market during the forecast period.
• Rising geriatric population and increasing severe wounds are expected to boost the market in the coming years.
• High cost of the biologic wound care products is estimated to hinder the market growth.
• Lack of awareness and training is projected to hamper the market growth.
• Increasing healthcare expenditure in developing countries is anticipated to propel the market in the coming years.
• Introduction of 3D printers is expected to create immense opportunities for the market players during the forecast period.

Scope of Wound Care Biologics Market Report

The report on the global wound care biologics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Wound Care Biologics Market Segment Insights

The biological skin substitutes segment accounted for a major market share in 2021

Based on products, the market is bifurcated into topical and biological skin substitutes. The biological skin substitutes segment is further segregated into xenograft and allograft. The biological skin substitutes segment accounted for a major market share in 2021. The need for bioengineered skin substitutes and operations has increased recently.

Additionally, recent developments in skin tissue engineering have increased its use among surgeons, which is driving the segment. As a popular solution for skin grafts in reconstructive surgery, bioengineered skin and skin substitutes are one of the essential tools. When it comes to breast reconstruction, allogenic acellular dermal matrix is highly preferred.

Additionally, materials made from cellular dermal matrix are used to treat diabetic lower extremity ulcers. The topical segment is estimated to expand at a high CAGR during the forecast period. The need for topical treatments is anticipated to rise in response to increasing demand for cosmetic surgery and skin reconstruction. Active topical treatments often regulate the phases of tissue restoration.

Get Free Sample Report

The pressure ulcer segment is expected to grow at a rapid pace during the forecast period

On the basis of wound types, the market is segregated into burns, surgical wounds, pressure ulcers, venous leg ulcers, and diabetic foot ulcers. The diabetic foot ulcers segment held key market in 2021 and is projected to maintain its dominance during the forecast period. High blood sugar levels, which frequently induce hormonal imbalance and other disorders like chronic foot ulcers, are the main cause of diabetic wounds.

Clinical professionals usually prefer biologics for wound treatment that provide a moist environment for healing. Therefore, extensive use of wound care biologics in the prevention of chronic wounds is anticipated to drive the segment. The pressure ulcer segment is expected to grow at a rapid pace during the forecast period. Demand for biologics used in wound treatment is projected to increase as pressure wounds like bed sores increases.

Patients dealing with long-term illnesses like diabetes frequently heal slowly and are prone to bed sores. Moreover, people with bone diseases are frequently bedridden and experience bed sores. Additionally, pressure ulcers often lead to significant side effects such septic arthritis, sepsis, bacteremia, and cellulitis, which further fuels consumer demand for wound care biologics and drives the segment.

Get Free Sample Report

The hospitals segment held key market share in 2021

In terms of end-users, the market is fragmented into ambulatory surgical centers and hospitals. The hospitals segment held key market share in 2021. The growing use of wound care biologics in the treatment of patients with diabetic foot ulcers, pressure ulcers, and skin burns has a significant financial benefit.

Additionally, extensive use of allografts and other skin substitutes in the management of post-surgical wounds is projected to boost the segment during the forecast period. The ambulatory surgical centers segment is estimated to grow at a substantial rate during the forecast period. Ambulatory surgical centers provide low-cost procedures as they have low-cost structures compared to traditional hospitals.

North America dominated the market in 2021

On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2021. Growth of the segment is attributed to rising incidence of chronic diseases, increasing healthcare expenditure, and rising demand for enhanced wound treatment options such wound care biologics products.

Get Free Sample Report